Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
NCT00005616 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005616 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer |
| Official title | A Phase I Single Dose-Escalation Study of BIBH-1 in Patients With Colorectal Cancer Scheduled for Surgical Resection |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | conventional surgery, neoadjuvant therapy, radionuclide imaging, iodine I 131 monoclonal antibody F19 |
| Enrollment | 12 |
| Start date | Sep 1, 1999 |
| Primary completion | Aug 1, 2000 |
| Completion | Aug 1, 2000 |
| First posted | Jun 18, 2004 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: